Select Prenatal Environmental Exposures and Subsequent Alterations of Gene-Specific and Repetitive Element DNA Methylation in Fetal Tissues

Current environmental health reports

Volumn 2, Issue 2, 2015, Pages 126-136

  Green, Benjamin B ^a   Marsit, Carmen J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Development; Developmental origins of adult disease; Epigenetics; Placenta

Indexed keywords

HEAVY METAL; PASSIVE SMOKING;

ADVERSE EFFECTS; ANIMAL; CHILD; DNA METHYLATION; DRUG EFFECTS; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS; GENETIC EPIGENESIS; HUMAN; MATERNAL EXPOSURE; METABOLISM; PASSIVE SMOKING; PLACENTA; PREGNANCY;

ANIMALS; CHILD; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; EPIGENESIS, GENETIC; FEMALE; FETUS; HUMANS; MATERNAL EXPOSURE; METALS, HEAVY; PLACENTA; PREGNANCY; TOBACCO SMOKE POLLUTION;

EID: 84943750901     PISSN: None     EISSN: 21965412     Source Type: Journal    
DOI: 10.1007/s40572-015-0045-0     Document Type: Review

References (99)

1. Hanson MA, Gluckman PD. Developmental origins of health and disease: new insights. Basic Clin Pharmacol Toxicol. 2008;102(2):90–3.
2. Jeltsch A, Jurkowska RZ. New concepts in DNA methylation. Trends Biochem Sci. 2014;39(7):310–8.
3. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature. 2007;447(7143):425–32.
4. Armstrong DA et al. Global and gene-specific DNA methylation across multiple tissues in early infancy: implications for children’s health research. FASEB J. 2014;28(5):2088–97.
5. Christensen B et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 2009;5(8):e1000602.
6. Novakovic B et al. Postnatal stability, tissue, and time specific effects of AHRR methylation change in response to maternal smoking in pregnancy. Epigenetics. 2013;9(3):377–86. Demonstrates the tissue specific nature of the alterations associated with cigarette smoke as well as the longevity of these changes.
7. Houseman E et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13(1):86.
8. Houseman EA, Molitor J, Marsit CJ. Reference-free cell mixture adjustments in analysis of DNA methylation data. Bioinformatics. 2014;30(10):1431–9. Introduces a technique that is able to account for cellular proportions when utilizing the 450K methylationarray technology. This allows for increased power in detection of true positives due to the ability to correct for different cell proportions across samples.
9. Novakovic B, Saffery R. The ever growing complexity of placental epigenetics—role in adverse pregnancy outcomes and fetal programming. Placenta. 2012;33(12):959–70.
10. Maccani MA, Marsit CJ. Epigenetics in the placenta. Am J Reprod Immunol. 2009;62(2):78–89.
11. Banister CE et al. Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas. Epigenetics. 2011;6(7):920–7.
12. Rehan V et al. Perinatal nicotine exposure induces asthma in second generation offspring. BMC Medicine. 2012;10(1):129.
13. Lawrence J et al. Foetal nicotine exposure causes PKCε gene repression by promoter methylation in rat hearts. Cardiovasc Res. 2011;89(1):89–97.
14. Dhimolea E et al. Prenatal exposure to BPA alters the epigenome of the rat mammary gland and increases the propensity to neoplastic development. PLoS One. 2014;9(7):e99800.
15. Jefferson W et al. Persistently altered epigenetic marks in the mouse uterus after neonatal estrogen exposure. Mol Endocrinol. 2013;27(10):1666–77.
16. Kundakovic M et al. Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure. Proc Natl Acad Sci. 2013;110(24):9956–61.
17. Castillo P et al. Impact of cadmium exposure during pregnancy on hepatic glucocorticoid receptor methylation and expression in rat fetus. PLoS One. 2012;7(9):e44139.
18. Tsang V et al. The epigenetic effects of a high prenatal folate intake in male mouse fetuses exposed in utero to arsenic. Toxicol Appl Pharmacol. 2012;264(3):439–50.
19. Ge Z-J et al. Maternal obesity and diabetes may cause DNA methylation alteration in the spermatozoa of offspring in mice. Reprod Biol Endocrinol. 2014;12(1):29.
20. Breton CV et al. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med. 2009;180(5):462–7.
21. Guerrero-Preston R et al. Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds. Epigenetics. 2010;5(6):539–46.
22. Suter M et al. In utero tobacco exposure epigenetically modifies placental CYP1A1 expression. Metabolism. 2010;59(10):1481–90.
23. Suter M et al. Maternal tobacco use modestly alters correlated epigenome-wide placental DNA methylation and gene expression. Epigenetics. 2011;6(11):1284–94.
24. Toledo-Rodriguez M et al. Maternal smoking during pregnancy is associated with epigenetic modifications of the brain-derived neurotrophic factor-6 exon in adolescent offspring. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(7):1350–4.
25. Maccani JZ et al. Placental DNA methylation alterations associated with maternal tobacco smoking at the RUNX3 gene are also associated with gestational age. Epigenomics. 2013;5(6):619–30.
26. Stroud LR et al. Maternal smoking during pregnancy and infant stress response: test of a prenatal programming hypothesis. Psychoneuroendocrinology. 2014;48:29–40.
27. Nahar MS et al. Bisphenol A-associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver. Environ Mol Mutagen. 2014;55(3):184–95.
28. LaRocca J et al. The impact of first trimester phthalate and phenol exposure on IGF2/H19 genomic imprinting and birth outcomes. Environ Res. 2014;133:396–406. Demonstrates the association between early pregnancy phthalate exposure and alterations to DNAmethylation at the IGF2/H19 gene cluster. This is an imprinted region and critical for proper development.
29. Kile ML et al. Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ Health Perspect. 2012;120(7):1061–6.
30. Kile ML et al. Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014;9(5):774–82. Highlights the role of arsenic exposure in utero to not only DNA methylation, but also to leukocyte proportions.
31. Koestler D et al. Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero. Environ Health Perspect. 2013;121(8):971–7. Associates in utero arsenic exposure with broad changes to cord blood DNA methylation levels.
32. Broberg K et al. Arsenic exposure in early pregnancy alters genome-wide DNA methylation in cord blood, particularly in boys. J Dev Orig Health Dis. 2014;5(4):288–98.
33. Kippler M et al. Sex-specific effects of early life cadmium exposure on DNA methylation and implications for birth weight. Epigenetics. 2013;8(5):494–503.
34. Senut M-C et al. Lead exposure disrupts global DNA methylation in human embryonic stem cells and alters their neuronal differentiation. Toxicol Sci. 2014;139(1):142–61.
35. Ruchat S-M et al. Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases. Epigenetics. 2013;8(9):935–43. Important for its demonstration that not only does maternal gestational diabetes affect infant DNAmethylation, but that this is occurring predominantly within genes that would have a subsequent role in the infant’s nutritional health.
36. Lesseur C et al. Maternal obesity and gestational diabetes are associated with placental leptin DNA methylation. Am J Obstet Gynecol. 2014;211(6):654.e1-9.
37. Houde A-A et al. Placental lipoprotein lipase DNA methylation levels are associated with gestational diabetes mellitus and maternal and cord blood lipid profiles. J Dev Orig Health Dis. 2014;2(5):132–41.
38. El Hajj N et al. Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus. Diabetes. 2013;62(4):1320–8.
39. Haggarty P et al. Folate in pregnancy and imprinted gene and repeat element methylation in the offspring. Am J Clin Nutr. 2013;97(1):94–9.
40. Hoyo C et al. Erythrocyte folate concentrations, CpG methylation at genomically imprinted domains, and birth weight in a multiethnic newborn cohort. Epigenetics. 2014;9(8):1120–30.
41. Lawson HA, Cheverud JM, Wolf JB. Genomic imprinting and parent-of-origin effects on complex traits. Nat Rev Genet. 2013;14(9):609–17.
42. Plasschaert RN, Bartolomei MS. Genomic imprinting in development, growth, behavior and stem cells. Development. 2014;141(9):1805–13.
43. Varvarigou A, Fouzas S, Beratis N. Effect of prenatal tobacco smoke exposure on fetal growth potential. J Perinat Med. 2010;38(6):683–7.
44. Aliyu M et al. Intrauterine exposure to tobacco and risk of medically indicated and spontaneous preterm birth. Am J Perinatol. 2010;27(5):405–10.
45. Miller EC et al. The risk of adverse pregnancy outcomes is increased in preeclamptic women who smoke compared with nonpreeclamptic women who do not smoke. Am J Obstet Gynecol. 2010;203(4):334.e1–8.
46. Knopik VS et al. The epigenetics of maternal cigarette smoking during pregnancy and effects on child development. Dev Psychopathol. 2012;24(Special Issue 04):1377–90.
47. Burke H et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics. 2012;129(4):735–44.
48. Riedel C et al. Parental smoking and childhood obesity: higher effect estimates for maternal smoking in pregnancy compared with paternal smoking—a meta-analysis. Int J Epidemiol. 2014;43(5):1593–606.
49. Wang L et al. Independent and joint effects of prenatal maternal smoking and maternal exposure to second-hand smoke on the development of adolescent obesity: a longitudinal study. J Paediatr Child Health. 2014;50(11):908–15.
50. Häsler J, Samuelsson T, Strub K. Useful ‘junk’: Alu RNAs in the human transcriptome. Cell Mol Life Sci. 2007;64(14):1793–800.
51. Zagrebelsky M, Korte M. Form follows function: BDNF and its involvement in sculpting the function and structure of synapses. Neuropharmacology. 2014;76(Part C(0)):628–38.
52. Ninan I. Synaptic regulation of affective behaviors; role of BDNF. Neuropharmacology. 2014;76(Part C(0)):684–95.
53. Frey BN et al. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry. 2013;47(4):321–32.
54. Mahan AL, Ressler KJ. Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder. Trends Neurosci. 2012;35(1):24–35.
55. Ikegame T et al. DNA methylation of the BDNF gene and its relevance to psychiatric disorders. J Hum Genet. 2013;58(7):434–8.
56. Song Y et al. Altered DNA methylation status of human brain derived neurotrophis factor gene could be useful as biomarker of depression. Am J Med Genet B Neuropsychiatr Genet. 2014;165(4):357–64.
57. Joubert BR et al. 450K epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ Health Perspect. 2012;120(10):1425–31. A study that broadly implicates maternal smoking with DNA methylation utilizing the genome-wide 450K methylation array.
58. Philibert RA, Beach SRH, Brody GH. Demethylation of the aryl hydrocarbon receptor repressor as a biomarker for nascent smokers. Epigenetics. 2012;7(11):1331–8.
59. Philibert R et al. Changes in DNA methylation at the aryl hydrocarbon receptor repressor may be a new biomarker for smoking. Clinical Epigenetics. 2013;5(1):19.
60. Foster WG, Agzarian J. Toward less confusing terminology in endocrine disruptor research. J Toxicol Environ Health Part B. 2008;11(3–4):152–61.
61. Rubin BS. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol. 2011;127(1–2):27–34.
62. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci. 2007;104(32):13056–61.
63. Inoue H et al. Bisphenol a glucuronidation and excretion in liver of pregnant and nonpregnant female rats. Drug Metab Dispos. 2005;33(1):55–9.
64. Mahalingaiah S et al. Temporal variability and predictors of urinary bisphenol A concentrations in men and women. Environ Health Perspect. 2008;116(2):173–8.
65. Nordin M et al. Epigenetic regulation of the Igf2/H19 gene cluster. Cell Prolif. 2014;47(3):189–99.
66. Gilbert-Diamond D et al. Rice consumption contributes to arsenic exposure in US women. Proc Natl Acad Sci. 2011;108(51):20656–60.
67. Rahman A et al. Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh. Am J Epidemiol. 2009;169(3):304–12.
68. Rahman A et al. Arsenic exposure and risk of spontaneous abortion, stillbirth, and infant mortality. Epidemiology. 2010;21(6):797–804. doi:10.1097/EDE.0b013e3181f56a0d.
69. Reichard JF, Schnekenburger M, Puga A. Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem Biophys Res Commun. 2007;352(1):188–92.
70. Zhao CQ et al. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci. 1997;94(20):10907–12.
71. Järup L, Åkesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol. 2009;238(3):201–8.
72. Olsson I-M et al. Cadmium in blood and urine—impact of sex, age, dietary intake, iron status, and former smoking–association of renal effects. Environ Health Perspect. 2002;110(12):1185–90.
73. Kippler M et al. Maternal cadmium exposure during pregnancy and size at birth: a prospective cohort study. Environ Health Perspect. 2012;120(2):284–9.
74. Yang K et al. Cadmium reduces 11β-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells. Am J Physiol Endocrinol Metab. 2006;290:E135–42.
75. Bellinger DC. Prenatal exposures to environmental chemicals and children’s neurodevelopment: an update. Saf Health Work. 2013;4(1):1–11.
76. Liu JA et al. Lead exposure at each stage of pregnancy and neurobehavioral development of neonates. NeuroToxicology. 2014;44:1–7.
77. Bellinger DC. Very low lead exposures and children’s neurodevelopment. Curr Opin Pediatr. 2008;20(2):172–7. doi:10.1097/MOP.0b013e3282f4f97b.
78. Schneider JS, Kidd SK, Anderson DW. Influence of developmental lead exposure on expression of DNA methyltransferases and methyl cytosine-binding proteins in hippocampus. Toxicol Lett. 2013;217(1):75–81.
79. Heijmans BT et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci. 2008;105(44):17046–9.
80. Tobi EW et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet. 2009;18(21):4046–53.
81. Mission JF, Marshall NE, Caughey AB. Obesity in pregnancy: a big problem and getting bigger. Obstet Gynecol Surv. 2013;68(5):389–99.
82. Lesseur C et al. Tissue-specific leptin promoter DNA methylation is associated with maternal and infant perinatal factors. Mol Cell Endocrinol. 2013;381(1–2):160–7. Demonstrates the downstream link between infant DNA methylation at the leptin gene and subsequent perinatal birth outcomes such as infant weight.
83. del Rosario MC et al. Potential epigenetic dysregulation of genes associated with MODY and type 2 diabetes in humans exposed to a diabetic intrauterine environment: an analysis of genome-wide DNA methylation. Metabolism. 2014;63(5):654–60.
84. Nomura Y et al. Global methylation in the placenta and umbilical cord blood from pregnancies with maternal gestational diabetes, preeclampsia, and obesity. Reprod Sci. 2014;21(1):131–7.
85. Zeisel SH. Importance of methyl donors during reproduction. Am J Clin Nutr. 2009;89(2):673S–7S.
86. Dominguez-Salas P et al. Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat Commun. 2014;5:3746.
87. Vidal AC et al. Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int J Obes. 2013;37(7):907–13.
88. Amarasekera M et al. Genome-wide DNA methylation profiling identifies a folate-sensitive region of differential methylation upstream of ZFP57-imprinting regulator in humans. FASEB J. 2014;28(9):4068–76.
89. Zuo X et al. Zinc finger protein ZFP57 requires its co-factor to recruit DNA methyltransferases and maintains DNA methylation imprint in embryonic stem cells via its transcriptional repression domain. J Biol Chem. 2012;287(3):2107–18.
90. Quenneville S et al. In embryonic stem cells, ZFP57/KAP1 recognize a methylated hexanucleotide to affect chromatin and DNA methylation of imprinting control regions. Mol Cell. 2011;44(3):361–72.
91. Tycko B. Imprinted genes in placental growth and obstetric disorders. Cytogenet Genome Res. 2006;113(1–4):271–8.
92. Prevention of neural tube defects. Standards for maternal and neonatal care. Geneva: World Health Organization (WHO); 2006.
93. Mikael LG et al. Moderately high intake of folic acid has a negative impact on mouse embryonic development. Birth Defects Res Part A: Clin Mol Teratol. 2013;97(1):47–52.
94. Pickell L et al. High intake of folic acid disrupts embryonic development in mice. Birth Defects Res Part A: Clin Mol Teratol. 2011;91(1):8–19.
95. Iglesias-Platas I et al. Altered expression of the imprinted transcription factor PLAGL1 deregulates a network of genes in the human IUGR placenta. Hum Mol Genet. 2014;23(23):6275–85.
96. Mandò C et al. Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia. Am J Physiol Endocrinol Metab. 2014;306:E404–13.
97. Zhao M et al. Placental expression of VEGF is increased in pregnancies with hydatidiform mole: possible association with developing very early onset preeclampsia. Early Hum Dev. 2013;89(8):583–8.
98. Yang M. et al. IgG expression in trophoblasts derived from placenta and gestational trophoblastic disease and its role in regulating invasion. Immunol Res. 2014;60(1):91–104.
99. Nitert M et al. Increased placental expression of fibroblast growth factor 21 in gestational diabetes mellitus. J Clin Endocrinol Metab. 2014;99(4):E591–8.